Real‐world efficacy of sofosbuvir plus velpatasvir therapy for patients with hepatitis C virus‐related decompensated cirrhosis-Reference-Cited by-同舟云学术

Real‐world efficacy of sofosbuvir plus velpatasvir therapy for patients with hepatitis C virus‐related decompensated cirrhosis

Published:2020-09-11 Issue:11 Volume:50 Page:1234-1243
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Ohya Kazuki¹²,Imamura Michio¹²,Teraoka Yuji¹²,Morio Kei¹²,Fujino Hatsue¹²,Nakahara Takashi¹²,Ono Atsushi¹²,Murakami Eisuke¹²,Kawaoka Tomokazu¹²^ORCID,Miki Daiki¹²,Tsuge Masataka²³,Hiramatsu Akira¹²,Aikata Hiroshi¹²^ORCID,Hayes C. Nelson¹²,Mori Nami⁴,Takaki Shintaro⁴,Tsuji Keiji⁴,Aisaka Yasuyuki⁵,Ishitobi Tomokazu⁶,Katamura Yoshio⁷,Kodama Hideaki⁸,Nabeshima Yoshitaka⁹,Masaki Keiichi¹⁰,Honda Yohji¹⁰,Moriya Takashi¹¹,Kohno Hirotaka¹²,Kohno Hiroshi¹²,Chayama Kazuaki¹²¹³^ORCID

Affiliation:

1. Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Science Hiroshima University Hiroshima Japan

2. Research Center for Hepatology and Gastroenterology Hiroshima University Hiroshima Japan

3. Natural Science Center for Basic Research and Development Hiroshima University Hiroshima Japan

4. Department of Gastroenterology/Liver Center Hiroshima Red Cross Hospital and Atomic‐bomb Survivors Hospital Hiroshima Japan

5. Department of Gastroenterology and Hepatology JA Hiroshima General Hospital Hatsukaichi Japan

6. Department of Gastroenterology JA Yoshida General Hospital Akitakata Japan

7. Department of Gastroenterology JA Onomichi General Hospital Onomichi Japan

8. Department of Hepatology Hiroshima‐Nishi Medical Center Otake Japan

9. Department of Internal Medicine, Chuden Hospital, The Chugoku Electric Power Company Hiroshima Japan

10. Department of Gastroenterology Hiroshima City Asa Citizens Hospital Hiroshima Japan

11. Department of Gastroenterology, Chugoku Rousai Hospital Kure Japan

12. Department of Gastroenterology Kure Medical Center Kure Japan

13. RIKEN Center for Integrative Medical Sciences Yokohama Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13555

Reference26 articles.

1. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus

2. Prognosis of chronic hepatitis c: Results of a large, prospective cohort study

3. Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group

4. Real-world virological efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C virus genotype 1 infection in Japan

5. The “real-world” efficacy and safety of DAAs for the treatment of HCV patients throughout Japan

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significance of portal venous blood flow as a factor to determine liver function in patients with decompensated cirrhosis due to hepatitis C virus infection following achievement of sustained viral response by sofosbuvir plus velpatasvir;Hepatology Research;2023-06-15

2. Necessity for surveillance for hepatocellualr carcinoma in older patients with chronic hepatitis C who achieved sustained virological response;JGH Open;2023-05-29

3. Portal venous blood flows determine liver function in patients with decompensated cirrhosis due to HCV infection receiving successful sofosbuvir/velpatasvir therapy;2023-01-12

4. Effect of sofosbuvir and velpatasvir therapy on clinical outcome in hepatitis C virus patients with decompensated cirrhosis;Hepatology Research;2022-12-22

5. Improved Liver Function After Sustained Virologic Response Enhanced Prognosis in Hepatitis C with Compensated Advanced Liver Fibrosis;Digestive Diseases and Sciences;2022-12-16